Clinical Trial Update: YSPSL for Prevention of Delayed Graft Function Part B [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/2 study of YSPSL to prevent delayed graft function in kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Diseases

Drugs mentioned

• YSPSL

Snippet

Sponsor: Y's Therapeutics, Inc. | Conditions: Kidney Diseases | Phase 1, Phase 2 | Status: COMPLETED